Avapritinib treatment of KIT D816V-mutant atypical chronic myeloid leukemia

BACKGROUND: Atypical chronic myeloid leukemia (aCML) is a rare myelodysplastic/myeloproliferative neoplasm. There is no proven standard of care treatment and the only curative option available is hematopoietic stem cell transplant. In addition to traditional chemotherapy, targeted therapy has shown...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandow, Lyndsey, Heinrich, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248858/
https://www.ncbi.nlm.nih.gov/pubmed/37305181
http://dx.doi.org/10.1016/j.lrr.2023.100371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248858/
https://www.ncbi.nlm.nih.gov/pubmed/37305181
http://dx.doi.org/10.1016/j.lrr.2023.100371

Ejemplares similares